Literature DB >> 10710003

COLIA1 polymorphism contributes to bone mineral density to assess prevalent wrist fractures.

M Weichetová1, J J Stepán, D Michalská, T Haas, H A Pols, A G Uitterlinden.   

Abstract

Wrist fractures associated with postmenopausal women are only partially explained by osteoporosis. Recent studies have shown that polymorphism of an Spl binding site in the first intron of the collagen I alpha 1 gene (COLIA1) may determine risk for vertebral and nonvertebral fractures in post-menopausal women independent of bone mass. We investigated the relationship between the COLIA1 polymorphism, lumbar spine and femoral neck bone mineral density (BMD), ultrasound stiffness of the heel, anthropometric variables, and risk for wrist fractures in 126 Czech postmenopausal women with low bone mass who suffered one or more wrist fracture in the last 5 years and in 126 postmenopausal women with low bone mass without any fracture. Genotypes for the Spl COLIA1 polymorphism were determined by polymerase chain reaction, digestion with Ball restriction enzyme, and agarose gel electrophoresis. The test discriminates two alleles, S and s, which correspond to the presence of guanine and thymidine, respectively, at the first bases in the Spl-binding site in the first intron of the gene for CO-LIA1. No significant differences were found between the fracture and control group with regard to age, weight, and years since menopause. However, BMD of the lumbar spine and femoral neck and ultrasound stiffness of the heel were significantly lower in patients with prevalent wrist fracture. Femoral neck BMD was the strongest determinant of prevalent fracture of the wrist. COLIA1 genotyping significantly strengthened prediction of prevalent fracture of the wrist. After multivariate adjustment, women in the Ss group had 2.0 times the risk of the women in the SS group (95% confidence interval [CI] = 1.1-3.8), and the women in the ss group had 2.8 times the risk of the women in the SS group (95% CI = 0.5-14.6). The overall gene-dose effect was an odds ratio of 2.1 per copy of the "s" allele (95% CI = 1.2-3.8). In the stepwise logistic regression, COLIA1 acted synergistically with femoral neck BMD and weight in increasing prediction of wrist fracture. The results demonstrate that COLIA1 Sp1 polymorphism is associated with an increased risk of wrist fracture in postmenopausal women independent of BMD and may be helpful in clinical practice by identifying patients with an increased fracture risk.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10710003     DOI: 10.1016/s8756-3282(99)00280-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

1.  A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality.

Authors:  V Mann; E E Hobson; B Li; T L Stewart; S F Grant; S P Robins; R M Aspden; S H Ralston
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Collagen type I alpha1 Sp1 polymorphism, osteoporosis, and intervertebral disc degeneration in older men and women.

Authors:  S M F Pluijm; H W van Essen; N Bravenboer; A G Uitterlinden; J H Smit; H A P Pols; P Lips
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

Review 3.  Searching for genes underlying susceptibility to osteoporotic fracture: current progress and future prospect.

Authors:  S-F Lei; H Jiang; F-Y Deng; H-W Deng
Journal:  Osteoporos Int       Date:  2007-05-30       Impact factor: 4.507

4.  COL1A1 Sp1 variation and bone phenotypes in an Italian population.

Authors:  Francesca Marini; Simone Parri; Laura Masi; Simone Ciuffi; Andrea Guazzini; Sergio Fabbri; Ettore Luzi; Luisella Cianferotti; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2013-05

5.  Association analysis of the COL1A1 polymorphism with bone mineral density and prevalent fractures in Polish postmenopausal women with osteoporosis.

Authors:  Joanna Dytfeld; Michalina Marcinkowska; Natalia Drwęska-Matelska; Michał Michalak; Wanda Horst-Sikorska; Ryszard Słomski
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.